155 related articles for article (PubMed ID: 1730814)
1. Expression of growth hormone (GH)-releasing factor gene in GH-producing pituitary adenoma.
Wakabayashi I; Inokuchi K; Hasegawa O; Sugihara H; Minami S
J Clin Endocrinol Metab; 1992 Feb; 74(2):357-61. PubMed ID: 1730814
[TBL] [Abstract][Full Text] [Related]
2. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
Lamberts SW; Verleun T; Oosterom R
J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
[TBL] [Abstract][Full Text] [Related]
5. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas.
Hashimoto K; Koga M; Motomura T; Kasayama S; Kouhara H; Ohnishi T; Arita N; Hayakawa T; Sato B; Kishimoto T
J Clin Endocrinol Metab; 1995 Oct; 80(10):2933-9. PubMed ID: 7559877
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
Hulting AL; Wersäll J; Werner S
Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
[TBL] [Abstract][Full Text] [Related]
7. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
[TBL] [Abstract][Full Text] [Related]
10. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.
Thapar K; Kovacs K; Stefaneanu L; Scheithauer B; Killinger DW; Lioyd RV; Smyth HS; Barr A; Thorner MO; Gaylinn B; Laws ER
Am J Pathol; 1997 Sep; 151(3):769-84. PubMed ID: 9284826
[TBL] [Abstract][Full Text] [Related]
12. Urocortin expression in human pituitary gland and pituitary adenoma.
Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
[TBL] [Abstract][Full Text] [Related]
13. Calcium homeostasis in growth hormone (GH)-secreting adenoma cells: effect of GH-releasing factor.
Dufy-Barbe L; Bresson L; Sartor P; Odessa MF; Dufy B
Endocrinology; 1992 Sep; 131(3):1436-44. PubMed ID: 1505473
[TBL] [Abstract][Full Text] [Related]
14. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
15. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.
Greenman Y; Melmed S
J Clin Endocrinol Metab; 1994 Sep; 79(3):724-9. PubMed ID: 7521350
[TBL] [Abstract][Full Text] [Related]
16. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.
Asa SL; Scheithauer BW; Bilbao JM; Horvath E; Ryan N; Kovacs K; Randall RV; Laws ER; Singer W; Linfoot JA
J Clin Endocrinol Metab; 1984 May; 58(5):796-803. PubMed ID: 6423659
[TBL] [Abstract][Full Text] [Related]
17. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
18. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of pit-1 cDNA from porcine anterior pituitary and its involvement in pituitary stimulation by growth hormone-releasing factor.
Chung HO; Kato T; Tomizawa K; Kato Y
Exp Clin Endocrinol Diabetes; 1998; 106(3):203-10. PubMed ID: 9710361
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
